Apros Therapeutics, Inc.
Apros Tx is a drug discovery and development company focused on immunotherapeutics for cancer and infectious disease.
2 employees · est. 2016 · San Diego, United States
Tyligand Bioscience
Innovative small molecule therapeutics for cancer and autoimmune disease treatment.
4 employees · est. 2018
Apros Therapeutics, Inc. is the older company (2016 vs 2018).
Side-by-Side Comparison
| Metric | Apros Therapeutics, Inc. | Tyligand Bioscience |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | San Diego, United States | Not tracked yet |
| Employees | ||
| Employees | 2 | 4 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series A |
| Total Funding | ||
| Total Funding | Not tracked yet | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Drug Development, Immunotherapeutics, Cancer Treatment, Infectious Disease, Tissue-targeted Therapy, Small Molecule Agonists, Tumor Immunogenicity, Cold Tumors, Hot Tumors, Chemistry Approaches, Precision Medicine, Innate Immune System, Biopharmaceuticals, Cancer Therapeutics | Small Molecule Therapeutics, Cancer Treatment, Autoimmune Disease Treatment, Drug Discovery, Pharmaceuticals, Medicine, Oncology, Immunology, Patient Health, Tumor Targeting, Health Outcomes |
| Website | ||
| Website | aprostx.com | tyligand.com |
About Apros Therapeutics, Inc.
Apros Therapeutics, Inc. is a biotechnology company founded in 2016 and headquartered in the United States. The company's focus lies in the development of tissue-targeted small molecule innate immune agonists to enhance tumor immunogenicity, with a specific emphasis on immunotherapeutics for cancer...
About Tyligand Bioscience
Tyligand Bioscience is a biotechnology company founded in 2018 with a focus on developing innovative small molecule therapeutics for cancer and autoimmune disease treatment. Their commitment to discovering and developing small molecule therapeutics has attracted significant investment, with the late...
We will tell you when either one moves
BounceWatch watches Apros Therapeutics, Inc. and Tyligand Bioscience for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Apros Therapeutics, In... and Tyligand Bioscience — by email.
Frequently Asked Questions
Compare Apros Therapeutics, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Apros Therapeutics, Inc. on 27 Oct 2024, and Tyligand Bioscience on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
